Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa

Schizophrenia Research

Volumn 76, Issue 1, 2005, Pages 89-97

  Patterson, Betty D ^a,b   Swingler, Dave ^a,c   Willows, Sandi ^c  

^a RHODES UNIVERSITY   (South Africa)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c Fort England Hospital   (South Africa)

Author keywords

Antioxidant; Antipsychotic; Tardive dyskinesia; Xhosa

Indexed keywords

ANTIOXIDANT; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE; PIPOTIAZINE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL DECANOATE;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FOOD INTAKE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; ONION; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SMOKING; SOUTH AFRICA; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; DYSKINESIA, DRUG-INDUCED; FEMALE; FOOD HABITS; HUMANS; INCIDENCE; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; POPULATION GROUPS; RISK FACTORS; SMOKING; SOUTH AFRICA;

EID: 20444449202     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.10.009     Document Type: Article

References (54)

1. L.A. Adler, J. Rotrosen, R. Edoson, P. Lavori, J. Lohr, R. Hitzemann, D. Raisch, M. Caligiuri, and K. Tracy Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group Arch. Gen. Psychiatry 56 1999 836 841
2. T.N. Ahrens, J.J. Sramek, J.M. Herrera, C.M. Jewett, and V.E. Alcorn Pharmacy-based screening program for tardive dyskinesia Drug. Intel. Clin. Pharm. 22 1988 205 208
3. M. Atkins, A. Burgess, C. Bottomley, and M. Riccio Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications Psychiatr. Bull. 21 1997 224 226
4. R.J Baldessarini Clinical and epidemiologic aspects of tardive dyskinesia J. Clin. Psychiatry 46 4 Pt 2 1985 8 13
5. R.J. Baldessarini Chemotherapy in Psychiatry 1985 Harvard Univ. Press Boston 22
6. D.P. Bassitt, and M.R. Louza Neto Clozapine efficacy in tardive dyskinesia in schizophrenic patients Eur. Arch. Psychiatry Clin. Neurosci. 248 1998 209 211
7. R.L. Binder, H. Kazamatsuri, T. Nishimura, and D.E. McNiel Smoking and tardive dyskinesia Biol. Psychiatry 22 1987 1280 1282
8. K.H. Boomershine, P.S. Shelton, and J.E. Boomershine Vitamin E in the treatment of tardive dyskinesia Ann. Pharmacother. 33 1999 1195 2202
9. S. Brink, D.H.J. Niehaus, L. Koen, J. Muller, and R.A. Emsley Tardive dyskinesia in a Xhosa population with schizophrenia: a descriptive study Abstr. S. Afr. J. Psychiatry 9 2003 46
10. British National Formulary 44, 2002. British Medical Association, London, p178.
11. R. Cavallaro, M.G. Regazzetti, E. Mundo, V. Brancato, and E. Smeraldi Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence Neuropsychopharmacology 8 1993 233 239
12. M.H. Chakos, J.M. Alvir, M.G. Woerner, A. Koreen, S. Geisler, D. Mayerhoff, S. Sobel, J.M. Kane, M. Borenstein, and J.A. Lieberman Incidence and correlates of tardive dyskinesia in first episode of schizophrenia Arch. Gen. Psychiatry 53 1996 313 319
13. S. Chong, R. Mahendran, D. Machin, H. Chua, G. Parker, and J. Kane Tardive dyskinesia among Chinese and Malay patients with schizophrenia J. Clin. Psychopharmacol. 22 2002 26 30
14. S. Chong, E. Tan, C. Tan, and M.B. Mythily Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene J. Psychiatry Neurosci. 28 2003 185 189
15. G. Chouinard, L. Annable, P. Mercier, and A. Ross-Chouinard A five-year follow-up study of tardive dyskinesia Psychopharmacol. Bull. 22 1986 259 263
16. G.E. Crane, and R.A. Smeets Tardive dyskinesia and drug therapy in geriatric patients Arch. Gen. Psychiatry 30 1974 341 343
17. R. Emsley, H.J. Turner, J. Schronen, K. Botha, R. Smit, and P.P. Oosthuizen A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia J. Clin. Psychiatry 65 2004 696 701
18. G. Gardos, D.E. Casey, J.O. Cole, A. Perenyi, E. Kocsis, M. Arato, J.A. Samson, and D. Conley Ten-year outcome of tardive dyskinesia Am. J. Psychiatry 151 1994 836 841
19. N. Gatere, C.J. Othieno, and D.M. Kathuku Prevalence of tardive dyskinesia among psychiatric in-patients at Mathari hospital, Nairobi East Afr. Med. J. 79 2002 547 549
20. W.M. Glazer Review of incidence studies of tardive dyskinesia associated with typical antipsychotics J. Clin. Psychiatry 61 Suppl. 4 2000 15 20
21. W.M. Glazer, H. Morgenstern, and J.T. Doucette Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications J. Clin. Psychiatry 54 1993 133 139
22. W.M. Glazer, H. Morgenstern, and J. Doucette Race and tardive dyskinesia among outpatients at a CMHC Hosp. Commun. Psychiatry 45 1994 38 42
23. D.C. Goff, D.C. Henderson, and E. Amico Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects Am. J. Psychiatry 149 1992 1189 1194
24. T.J. Holden Tardive dyskinesia in long-term hospitalised Zulu psychiatric patients S. Afr. Med. J. 71 1987 88 90
25. D.V. Jeste Tardive dyskinesia rates with atypical antipsychotics in older adults J. Clin. Psychiatry 65 Suppl. 9 2004 21 24
26. D.V. Jeste, J.P. Lacro, B. Palmer, E. Rockwell, M.J. Harris, and M.P. Caligiuri Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients Am. J. Psychiatry 156 1999 309 311
27. J.M. Kane Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence J. Clin. Psychiatry 65 Suppl. 9 2004 16 20
28. J.M. Kane, and J.M. Smith Tardive dyskinesia. Prevalence and risk factors, 1959 to 1979 Arch. Gen. Psychiatry 39 1982 473 481
29. J.M. Kane, M. Woerner, M. Borenstein, J. Wegner, and J. Lieberman Integrating incidence and prevalence of tardive dyskinesia Psychopharmacol. Bull. 22 1986 254 259
30. J.M. Kane, M. Woerner, and J. Lieberman Tardive dyskinesia: prevalence, incidence, and risk factors J. Clin. Psychopharmacol. 8 4 Suppl. 1988 52S 56S
31. T. Kolakowska, A.O. Williams, M. Ardern, and M.A. Reveley Tardive dyskinesia in schizophrenics under 60 years of age Biol. Psychiatry 21 1986 161 169
32. J.B. Lohr, and M.P. Caliguiri A double-blind placebo controlled study of vitamin E treatment of tardive dyskinesia J Clin. Psychiatry 57 1996 167 173
33. J.B. Lohr, R. Kuczenski, and A.B. Niculescu Oxidative mechanisms and tardive dyskinesia CNS Drugs 17 2003 47 62
34. Lomond and Argyll Primary Care NHS Trust, 2001. Guidelines for psychiatrists on the prescription of antipsychotic drugs, including high doses for the treatment of schizophrenic illness. Website www.argyllnhs.org/uk/argyll- and-bute/mental_health.html, appendix 1 and 2.
35. M.A. Menza, N. Grossman, M. Van Horn, R. Cody, and N. Forman Smoking and movement disorders in psychiatric patients Biol. Psychiatry 30 1991 109 115
36. H. Morgenstern, and W.M. Glazer Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications Arch. Gen. Psychiatry 50 1993 723 733
37. P.S. Naidu, A. Singh, and S.K. Kulkarni Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia Neuropharmacology 44 2003 1100 1106
38. A. Nilsson, L. Waller, A. Rosengren, A. Adlerberth, and L. Wilhelmsen Cigarette smoking is associated with abnormal involuntary movements sin the general male population-a study of men born in 1933 Biol. Psychiatry 15 1997 717 723
39. P.P. Oosthuizen, R.A. Emsley, J.S. Maritz, J.A. Turner, and N. Keyter Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol J. Clin. Psychiatry 64 2003 1075 1080
40. A. Pandurangi, and Y.A. Aderibigbe Tardive dyskinesia in non-western countries: a review Eur. Arch. Psychiatry Clin. Neurosci. 246 1995 47 52
41. M.A. Richardson, M.L. Bevans, L.L. Read, H.M. Chao, J.D. Clelland, R.F. Suckow, T.J. Maher, and L. Citrome Efficacy of branched-chain amino acids in the treatment of tardive dyskinesia in men Am. J. Psychiatry 160 2003 1117 1124
42. R.N. Schooler, and J.M. Kane Research diagnoses for tardive dyskinesia (letter) Arch. Gen. Psychiatry 39 1982 309 311
43. M.V. Seeman Tardive dyskinesia: two-year recovery Compr. Psychiatry 22 1981 189 192
44. K.C. Soares, and J.J. McGrath Vitamin E for neuroleptic-induced tardive dyskinesia Cochrane Database Syst. Rev. 4 2001 CD000209
45. J. Sramek, S. Roy, T. Ahrens, P. Pinanong, N.R. Cutler, and E. Pi Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients Hosp. Commun. Psychiatry 42 1991 590 592
46. J.L. Waddington, H.A. Youssef, and A. Kinsella Cognitive dysfunction in schizophrenia followed up over 5 years and its longitudinal relationship to the emergence of tardive dyskinesia Psychol. Med. 20 1990 835 842
47. M.G. Woerner, J.M. Alvir, B.L. Saltz, J.A. Lieberman, and J.M. Kane Prospective study of tardive dyskinesia in the elderly: rates and risk factors Am. J. Psychiatry 155 1998 1521 1528
48. S.W. Woods Chlorpromazine equivalent doses for the newer atypical antipsychotics J. Clin. Psychiatry 64 2003 663 667
49. B.A. Wszola, K.M. Newell, and R.L. Sprague Risk factors for tardive dyskinesia in a large population of youths and adults Exp. Clin. Psychopharmacol. 9 2001 285 296
50. R.J. Wyatt Practical Psychiatric Practice 2nd edn. 1998 American Psychiatric Publishing Arlington 01 26
51. R. Yassa, and V. Nair The association of tardive dyskinesia and pseudoparkinsonism Prog. Neuro-psychopharmacol. Biol. Psychiatry 12 1988 909 914
52. R. Yassa, V. Nair, and G. Schwartz Tardive dyskinesia. A two-year follow-up study Psychosomatics 25 1984 852 855
53. R. Yassa, S. Lal, A. Korpassy, and J. Ally Nicotine exposure and tardive dyskinesia Biol. Psychiatry 22 1987 67 72
54. D.M. Ziedonis, T.R. Kosten, W.M. Glazer, and R.J. Frances Nicotine dependence and schizophrenia Hosp. Commun. Psychiatry 45 1994 204 206